Class 3 recall- Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection

Class 3 Recall

Class 3 recall- Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection

Accord Healthcare Limited is recalling certain batches of Azacitidine Powder for Suspension for Injection 100 mg/vial and 150 mg/vial as precautionary measure due to out of specification results for Azacitidine related compound C impurity during stability testing.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-azacitidine-100-mg-slash-vial-and-150-mg-slash-vial-powder-for-suspension-for-injection-el-25-a-slash-08

MHRA ref: DMRC-34527566

Pip code	Product description	Supplier	Batch Numbers
1236629	AZACITADINE PDR INJ VIAL ACC 100mg	ACCORD	P2206998 P2300471
1262955	AZACITIDINE PDR VIAL 25MG/ML ACC 150mg	ACCORD	P2302576

Further Information

For medical information enquiries please contact Accord-UK Ltd Medical Information Department on 01271 385257 or email medinfo@accord-healthcare.com
For stock control enquiries please contact Accord-UK Ltd Customer Services Team on 0800 373573

Please return all affected stock to your original supplier for credit.

Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited).

Please note that anything not returned to us, or notified to us, within 12 weeks of this notification, cannot be reimbursed by way of a credit.